New drug for Kids' bleeding disorder under watch

NCT ID NCT07404644

Summary

This study is monitoring the safety and effectiveness of a drug called vonicog alfa (rVWF) in children under 18 with Von Willebrand disease, a condition that causes excessive bleeding. Doctors will give the drug as usual treatment for bleeding episodes or around surgery, and researchers will track any side effects and how well it works for one year. The goal is to gather real-world information on how this drug performs in pediatric patients in Japan.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VON WILLEBRAND DISEASE (VWD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Takeda selected site

    RECRUITING

    Tokyo, Tokyo, Japan

Conditions

Explore the condition pages connected to this study.